The Journal of Controlled Release is a bimonthly peer-reviewed medical journal and the official journal of the Controlled Release Society. The journal contains papers detailing research involving the controlled release and delivery of drugs and other biologically active agents. Announcements and reports of future meetings pertaining to the activities of the Controlled Release Society are also included. The journal is abstracted and indexed in BIOSIS Previews, CAB Abstracts, Chemical Abstracts, Current Contents/Life Sciences, EMBASE, MEDLINE, Science Citation Index, and Scopus.
While there are several thousand drugs available to treat a wide range of brain diseases, from depression to schizophrenia, they cannot penetrate the blood-brain barrier (BBB) into the brain. The BBB, which protects the brain ...
Jun 06, 2019
0
915
Resveratrol and quercetin, two polyphenols that have been widely studied for their health properties, may soon become the basis of an important new advance in cancer treatment, primarily by improving the efficacy and potential ...
Jul 16, 2015
0
36
Researchers at the University of North Carolina at Chapel Hill have used exosomes—tiny bubbles of protein and fat produced naturally by cells—to bypass the body's defenses and deliver a potent antioxidant directly to ...
May 04, 2015
0
147
Scientists at the University of Waterloo have developed a new tool to protect women from HIV infection.
Apr 16, 2018
0
207
Glaucoma, which affects over 60 million people worldwide, can seem easy to treat: medicated eye drops can be used to ease the buildup of fluid in the eye that underlies the condition. If glaucoma is caught early, eye drops ...
Nov 23, 2017
0
54
There are about 48,000 corneal transplants done each year in the U.S., compared to approximately 16,000 kidney transplants and 2,100 heart transplants. Out of the 48,000 corneal transplants done, 10 percent of them end up ...
Mar 09, 2015
0
7
An affordable, globally available drug – low-dose Aspirin – shows promise as a new approach to preventing HIV transmission, a University of Manitoba study has found.
Aug 10, 2018
0
60
Houston Methodist scientists have developed a nanodevice to deliver immunotherapy without side effects to treat triple-negative breast cancer. Inserted straight into a tumor, this nanofluidic seed makes it possible to deliver ...
Oct 23, 2018
0
603
An international team has designed the first potentially therapeutic photoactive drug, MRS7145, to fight Parkinson's disease, according to the new article in Journal of Controlled Release.
Jun 08, 2018
0
82
Cornell researchers have discovered potent cancer-killing proteins that can travel by white blood cells to kill tumors in the bloodstream of mice with metastatic prostate cancer. The breakthrough study will be published Feb. ...
Jan 12, 2016
0
33
